Literature DB >> 31036475

Feasibility of laparoscopy gastrectomy for gastric cancer in the patients with high body mass index: A systematic review and meta-analysis.

Lin Sun1, Bochao Zhao2, Youyi Huang3, Huiwen Lu2, Rui Luo2, Baojun Huang4.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the impact of high body mass index (BMI) on surgical outcome of laparoscopic gastrectomy for gastric cancer (GC).
METHODS: Systematic literature search was performed using PubMed and Embase databases. The relevant data were extracted, and surgical outcomes and postoperative complications were compared between BMI≥25 kg/m2 and BMI<25 kg/m2 group using a fixed effect model or random effect model.
RESULTS: 16 studies, with a total of 9572 GC patients, were included in this meta-analysis. The results indicated that operation time was significantly longer (WMD:16.22, 95% CI: 14.10-18.34, P < 0.001; I2 = 0%) and the number of lymph nodes retrieved was significantly fewer (WMD:-2.11, 95%CI: -3.14, -1.07, P < 0.001; I2 = 64.0%) in high BMI patients than in other patients. In addition, the amount of intraoperative blood loss was significantly larger in high BMI patients (WMD: 23.43, 95%CI: 20.05-26.81, P < 0.001; I2 = 40.3%). Compared with non-high BMI patients, overweight and obese patients had a higher risk of postoperative complications (RR:1.26, 95%CI: 1.11-1.43, P < 0.001; I2 = 39.1%), especially for wound infection (RR:1.62, 95%CI: 1.15-2.29, P < 0.01; I2 = 18.8%) and postoperative ileus (RR:1.80, 95% CI: 1.05-3.09, P < 0.05; I2 = 0%). However, there was no significant difference between two patient groups for postoperative recovery, major surgery-related complications (eg: anastomotic leakage, pancreatic fistula and intra-abdominal bleeding) and postoperative mortality.
CONCLUSION: Despite increased technical challenge and risk of postoperative complications, the majority of these complications may be minor and cured. Laparoscopic gastrectomy for GC was a feasible and safe procedure even for high BMI patients.
Copyright © 2019. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Body mass index (BMI); Gastric cancer; Laparoscopic gastrectomy; Obesity; Overweight; Postoperative complications

Year:  2019        PMID: 31036475     DOI: 10.1016/j.asjsur.2019.03.017

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  6 in total

1.  Impact of Excess Body Weight on Postsurgical Complications.

Authors:  Lars Plassmeier; Mohammed K Hankir; Florian Seyfried
Journal:  Visc Med       Date:  2021-08-02

2.  Advantages of a robotic approach compared with laparoscopy gastrectomy for patients with high visceral fat area.

Authors:  Makoto Hikage; Keiichi Fujiya; Yuhei Waki; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Akifumi Notsu; Masanori Terashima
Journal:  Surg Endosc       Date:  2022-03-16       Impact factor: 3.453

3.  Feasibility of totally laparoscopic total gastrectomy in obese patients with gastric cancer.

Authors:  Hideaki Suematsu; Chikara Kunisaki; Hiroshi Miyamato; Kei Sato; Sho Sato; Yusaku Tanaka; Norio Yukawa; Yasushi Rino; Takashi Kosaka; Itaru Endo; Munetaka Masuda
Journal:  Langenbecks Arch Surg       Date:  2021-11-06       Impact factor: 2.895

4.  Does high body mass index influence the postoperative complications and long-term survival in patients with esophageal squamous cell carcinoma after minimally invasive esophagectomy?

Authors:  Ying-Jian Wang; Tao Bao; Kun-Kun Li; Xiao-Long Zhao; Wei Guo
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-03-16       Impact factor: 1.627

5.  Nomogram of intra-abdominal infection after surgery in patients with gastric cancer: A retrospective study.

Authors:  Yue Zhang; Zhengfei Wang; Zarrin Basharat; Mengjun Hu; Wandong Hong; Xiangjian Chen
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

6.  Safety of subxiphoid uniportal video-assisted thoracoscopic surgery for anterior mediastinal tumour in obese patients.

Authors:  Weidong Wu; Chun Chen; Wei Zheng; Lin Huang; Pengqiang Gao; Yong Zhu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-13       Impact factor: 1.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.